SARS-COV-2 Spike S1+S2 ECD (S-ECD) protein (Recombinant) (C-His&Avi) (STJP020159)
SPECIFICATIONS
HostHEK293 cells
ConjugationUnconjugated
ImmunogenRecombinant SARS-COV-2 Spike S Trimer (D614G) Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Val16-Glu1188 (D614G) ) of SARS-COV-2 Spike S Trimer (D614G) fused with a His tag and Avi at the C-terminal
General Information
| Short Description | Recombinant-SARS-COV-2 Spike S1+S2 ECD (S-ECD)-C-His&Avi protein was developed in hek293 cells using the region D614G. For use in research applications. |
| Host | HEK293 cells |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | Unconjugated |
| Formulation | Lyophilised from a 0.22 Mu m filtered solution of PBS, pH 7.4. |
| Storage Instruction | Store at-20ยฐC for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method | < 1 EU/Mu g of the protein by LAL method. |
Target Information
| Immunogen | Recombinant SARS-COV-2 Spike S Trimer (D614G) Protein is produced by Expi293 expression system. The target protein is expressed with sequence (Val16-Glu1188 (D614G) ) of SARS-COV-2 Spike S Trimer (D614G) fused with a His tag and Avi at the C-terminal |
| Immunogen Region | D614G |